Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
Swedish agency approves Medivir's Xerclear for treatment of cold sores

Swedish agency approves Medivir's Xerclear for treatment of cold sores

Exposure to common infections may increase stroke risk

Exposure to common infections may increase stroke risk

University of Michigan to develop novel therapy for neuropathic pain

University of Michigan to develop novel therapy for neuropathic pain

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Women may need smaller dose of H1N1 vaccine

Women may need smaller dose of H1N1 vaccine

Chronic viruses found living in prostate tumors

Chronic viruses found living in prostate tumors

FDA approves Sirion's Zirgan for treating acute herpetic keratitis

FDA approves Sirion's Zirgan for treating acute herpetic keratitis

Phase II VICTOR-E1 clinical study results reported

Phase II VICTOR-E1 clinical study results reported

Corticosteroid and antiviral agent combination proves to be beneficial for treating Bell Palsy

Corticosteroid and antiviral agent combination proves to be beneficial for treating Bell Palsy

Condoms reduce risk of herpes simplex virus 2

Condoms reduce risk of herpes simplex virus 2

Oncolytics Biotech obtains 32nd U.S. Patent grant

Oncolytics Biotech obtains 32nd U.S. Patent grant

Nanoviricides anti-herpes drug candidate reduces viral load by 99.99%

Nanoviricides anti-herpes drug candidate reduces viral load by 99.99%

New research helps explain why treated genital herpes sores boost risk of HIV infection

New research helps explain why treated genital herpes sores boost risk of HIV infection

Herpes drug Acyclovir does not reduce risk of HIV transmission, does slow HIV progression, study says

Herpes drug Acyclovir does not reduce risk of HIV transmission, does slow HIV progression, study says

Immune cells in skin fight off infection better than the rest

Immune cells in skin fight off infection better than the rest

Discovery of protein that reactivates latent herpes simplex virus

Discovery of protein that reactivates latent herpes simplex virus

Male circumcision reduces risk of herpes simplex virus type 2 and human papillomavirus

Male circumcision reduces risk of herpes simplex virus type 2 and human papillomavirus

Gene-targeting approach for herpes treatment

Gene-targeting approach for herpes treatment

Early childhood stress has long-term implications

Early childhood stress has long-term implications

Topical treatment wipes out herpes with RNAi

Topical treatment wipes out herpes with RNAi